Busey Bank’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.39M | Sell |
8,223
-113
| -1% | -$19.3K | 0.04% | 164 |
|
|
2025
Q4 | $1.41M | Hold |
8,336
| – | – | 0.04% | 163 |
|
|
2025
Q3 | $1.2M | Sell |
8,336
-211
| -2% | -$28.8K | 0.03% | 166 |
|
|
2025
Q2 | $1.08M | Hold |
8,547
| – | – | 0.03% | 169 |
|
|
2025
Q1 | $1.09M | Sell |
8,547
-6,719
| -44% | -$911K | 0.04% | 165 |
|
|
2024
Q4 | $2.02M | Sell |
15,266
-19
| -0.1% | -$2.67K | 0.07% | 136 |
|
|
2024
Q3 | $2.23M | Sell |
15,285
-50
| -0.3% | -$7.24K | 0.07% | 134 |
|
|
2024
Q2 | $2.1M | Sell |
15,335
-229
| -1% | -$30.6K | 0.07% | 132 |
|
|
2024
Q1 | $2.14M | Sell |
15,564
-40
| -0.3% | -$5.46K | 0.08% | 135 |
|
|
2023
Q4 | $2.12M | Sell |
15,604
-160
| -1% | -$19.5K | 0.08% | 134 |
|
|
2023
Q3 | $1.93M | Sell |
15,764
-191
| -1% | -$24.3K | 0.08% | 128 |
|
|
2023
Q2 | $2.03M | Sell |
15,955
-96
| -0.6% | -$12.5K | 0.08% | 131 |
|
|
2023
Q1 | $2.07M | Sell |
16,051
-38
| -0.2% | -$4.97K | 0.09% | 131 |
|
|
2022
Q4 | $2.11M | Sell |
16,089
-5,535
| -26% | -$715K | 0.1% | 131 |
|
|
2022
Q3 | $2.53M | Sell |
21,624
-89
| -0.4% | -$11.1K | 0.13% | 123 |
|
|
2022
Q2 | $2.55M | Sell |
21,713
-64
| -0.3% | -$7.6K | 0.12% | 127 |
|
|
2022
Q1 | $2.84M | Sell |
21,777
-90
| -0.4% | -$11.7K | 0.11% | 133 |
|
|
2021
Q4 | $3.34M | Sell |
21,867
-2,952
| -12% | -$457K | 0.13% | 127 |
|
|
2021
Q3 | $4.01M | Buy |
24,819
+49
| +0.2% | +$8.25K | 0.16% | 114 |
|
|
2021
Q2 | $4.05M | Sell |
24,770
-58
| -0.2% | -$8.93K | 0.19% | 104 |
|
|
2021
Q1 | $3.74M | Sell |
24,828
-5
| -0% | -$794 | 0.19% | 104 |
|
|
2020
Q4 | $3.76M | Sell |
24,833
-289
| -1% | -$41.3K | 0.22% | 98 |
|
|
2020
Q3 | $3.4M | Sell |
25,122
-249
| -1% | -$33.8K | 0.22% | 102 |
|
|
2020
Q2 | $3.47M | Sell |
25,371
-435
| -2% | -$55.5K | 0.24% | 96 |
|
|
2020
Q1 | $2.78M | Sell |
25,806
-553
| -2% | -$63.7K | 0.23% | 100 |
|
|
2019
Q4 | $3.18M | Sell |
26,359
-307
| -1% | -$34.3K | 0.21% | 108 |
|
|
2019
Q3 | $2.65M | Sell |
26,666
-5
| -0% | -$523 | 0.19% | 111 |
|
|
2019
Q2 | $2.91M | Sell |
26,671
-5,382
| -17% | -$572K | 0.28% | 82 |
|
|
2019
Q1 | $3.58M | Sell |
32,053
-247
| -0.8% | -$27.1K | 0.33% | 75 |
|
|
2018
Q4 | $3.11M | Buy |
+32,300
| New | +$3.43M | 0.32% | 75 |
|
|
2018
Q1 | – | Sell |
-18,836
| Closed | -$2.01M | – | 200 |
|
|
2017
Q4 | $2.01M | Buy |
+18,836
| New | +$2.01M | 0.26% | 82 |
|
Other funds holding IBB
CB
Busey Bank's IBB Position: Q1 2026 in Review
Busey Bank reduced its iShares Biotechnology ETF (IBB) stake by 1.4% in Q1 2026, selling an estimated $19.3K and leaving 8,223 shares worth $1.39M. The position accounts for 0.04% of the portfolio, ranked #164.
Busey Bank first reported a position in IBB in Q4 2017 and has held it in 31 quarters since. The position peaked at $4.05M in Q2 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Busey Bank held 8,223 shares of iShares Biotechnology ETF worth $1.39M as of Q1 2026.
- Busey Bank sold 113 iShares Biotechnology ETF shares in Q1 2026, an estimated $19.3K.
- iShares Biotechnology ETF made up 0.04% of Busey Bank's portfolio in Q1 2026, its #164 holding.
- Busey Bank first reported a position in iShares Biotechnology ETF in Q4 2017 and has held it in 31 quarters since.
- Busey Bank's iShares Biotechnology ETF position peaked at $4.05M in Q2 2021.
- 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Busey Bank's 13F filing for Q1 2026, filed 28 Apr 2026.